ENDOGENOUS RESTORATION OF NORADRENALINE BY PRECURSOR THERAPY IN DOPAMINE-BETA-HYDROXYLASE DEFICIENCY
Open Access
- 1 November 1987
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 330 (8569), 1170-1172
- https://doi.org/10.1016/s0140-6736(87)91317-1
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- CONGENITAL DOPAMINE-BETA-HYDROXYLASE DEFICIENCY: A Novel Orthostatic SyndromeThe Lancet, 1987
- Isolated Failure of Autonomic Noradrenergic NeurotransmissionNew England Journal of Medicine, 1986
- Mass spectrometric measurements of norepinephrine synthesis in man from infusion of stable isotope-labelled L-threo-3, 4-dihydroxyphenylserineLife Sciences, 1985
- Treatment of parkinsonism with L‐thereo‐3, 4‐dihydroxyphenylserineNeurology, 1984
- Increased vascular beta2-adrenoceptor responsiveness in autonomic dysfunctionJournal of the American College of Cardiology, 1984
- Influence of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines in humans.Hypertension, 1983
- Pressor effect of L-threo-3,4-dihydroxyphenylserine in ratsJournal of Pharmacy and Pharmacology, 1981
- Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamineLife Sciences, 1977
- Formation of noradrenaline in the rat brain from the four stereoisomers of 3,4-dihydroxyphenylserineNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1974
- The Urinary Output of Catecholamines in Narcolepsy Under Resting Conditions and Following Administration of Dopamine, Dopa, and DopsScandinavian Journal of Clinical and Laboratory Investigation, 1966